Published in Behav Brain Res on May 16, 2008
Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer (2009) 2.92
Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int J Gen Med (2011) 1.64
Public health challenges of electronic cigarettes in South Korea. J Prev Med Public Health (2011) 1.50
SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study. Nucleic Acids Res (2010) 1.29
Nicotinic acetylcholine receptor genes on chromosome 15q25.1 are associated with nicotine and opioid dependence severity. Hum Genet (2010) 1.12
The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer. Prog Neurobiol (2010) 1.09
Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol (2011) 1.08
Breaking barriers in the genomics and pharmacogenetics of drug addiction. Clin Pharmacol Ther (2010) 1.05
Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation. Cell Commun Signal (2009) 1.05
Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet (2011) 1.03
Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors. Eur J Neurosci (2009) 1.00
15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology (2013) 0.97
Age-related differences in working memory deficits during nicotine withdrawal. Addict Biol (2013) 0.96
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning. Neurobiol Learn Mem (2013) 0.93
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet (2012) 0.92
Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus. Psychopharmacology (Berl) (2012) 0.90
Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity. Pharmacogenet Genomics (2010) 0.89
Individual differences in oral nicotine intake in rats. Neuropharmacology (2011) 0.88
Lung carcinoma signaling pathways activated by smoking. Chin J Cancer (2011) 0.87
From smoking to lung cancer: the CHRNA5/A3/B4 connection. Oncogene (2010) 0.87
Cognitive effects of nicotine: genetic moderators. Addict Biol (2010) 0.85
Effects of delta opioid receptors activation on a response inhibition task in rats. Psychopharmacology (Berl) (2010) 0.84
nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives. Schizophr Res (2016) 0.84
The Oncogenic Functions of Nicotinic Acetylcholine Receptors. J Oncol (2016) 0.80
The relationship between rs3779084 in the dopa decarboxylase (DDC) gene and alcohol consumption is mediated by drinking motives in regular smokers. Alcohol Clin Exp Res (2011) 0.80
Genetic analysis of the psychostimulant effects of nicotine in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors. Mamm Genome (2008) 0.79
Oral Nicotine Self-Administration in Rodents. J Addict Res Ther (2012) 0.79
Genetic matters: thirty years of progress using mouse models in nicotinic research. Biochem Pharmacol (2013) 0.78
Nicotinic acetylcholine receptor α7 and β4 subunits contribute nicotine-induced apoptosis in periodontal ligament stem cells. Mol Cells (2012) 0.78
New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology (2014) 0.77
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice. Behav Pharmacol (2015) 0.77
Strain-dependent performance in nicotine-induced conditioned place preference. Behav Neurosci (2014) 0.75
Nine generations of selection for high and low nicotine intake in outbred Sprague-Dawley rats. Behav Genet (2013) 0.75
The future of genetic studies of complex human diseases. Science (1996) 64.76
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet (1995) 49.77
Genome-wide association studies for common diseases and complex traits. Nat Rev Genet (2005) 33.96
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature (2008) 18.21
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet (2008) 16.17
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet (2005) 14.30
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16
Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. MMWR Morb Mortal Wkly Rep (2005) 8.10
Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90
Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2004) 7.89
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry (2008) 6.37
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature (1998) 6.27
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem (2005) 6.13
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science (2004) 5.94
Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res (2007) 5.57
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med (1988) 4.98
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2007) 4.62
Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol (2004) 4.58
Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci (2001) 4.58
A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (2003) 4.37
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature (2005) 4.15
Stages in the development of adolescent smoking. Drug Alcohol Depend (2000) 4.14
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol (2006) 3.84
Nicotine dependence in the United States: prevalence, trends, and smoking persistence. Arch Gen Psychiatry (2001) 3.82
A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med (1999) 3.78
Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) (2006) 3.68
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature (1995) 3.28
Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med (2004) 3.26
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci (2001) 3.05
Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry (1999) 3.04
Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci (1997) 2.87
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet (2005) 2.80
Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology (2007) 2.73
Motivational influences on cigarette smoking. Annu Rev Psychol (2004) 2.61
Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry (2002) 2.60
Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry (1991) 2.51
The report of the Surgeon General: preventing tobacco use among young people. Am J Public Health (1994) 2.49
A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet (2004) 2.47
Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry (2005) 2.36
Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev (2006) 2.33
Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (2007) 2.27
The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol (2002) 2.20
Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus (1998) 2.19
The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry (2007) 2.19
Heritability of smoking initiation and nicotine dependence. Behav Genet (2005) 2.15
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature (1999) 2.13
Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci (1999) 2.12
The genetics of smoking persistence in men and women: a multicultural study. Behav Genet (1999) 2.11
Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci (2002) 2.05
Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther (2008) 2.04
Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol (1993) 2.02
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron (1999) 2.01
The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol (2003) 2.00
Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol (2003) 1.99
Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci (2004) 1.99
Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech Dev (1999) 1.98
Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. J Stud Alcohol (1999) 1.97
Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci (2002) 1.96
Genetic and environmental influences on adolescent substance use and abuse. Am J Med Genet (2000) 1.92
Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry (2006) 1.89
The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behav Genet (1999) 1.88
Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci (2002) 1.88
Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci (2003) 1.87
Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuropsychiatr Genet (2007) 1.82
Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (1999) 1.81
Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction (1994) 1.80
Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci (1997) 1.79
Predictors of susceptibility to smoking and ever smoking: a longitudinal study in a triethnic sample of adolescents. Nicotine Tob Res (2003) 1.77
The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) (2006) 1.76
Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J Pharmacol Exp Ther (2001) 1.74
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci (2003) 1.73
Genomic copy number and expression variation within the C57BL/6J inbred mouse strain. Genome Res (2007) 1.71
Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence. Addict Behav (2005) 1.69
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci (2005) 1.68
Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci (1996) 1.65
Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther (2003) 1.64
Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci (2000) 1.64
Assembly and subunit diversity of nicotinic acetylcholine receptors. Biochem Soc Trans (2003) 1.62
Nicotine enhancement of contextual fear conditioning. Behav Brain Res (1999) 1.57
The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Hum Mol Genet (2007) 1.57
The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res (2003) 1.57
A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend (1999) 1.57
Genetic and environmental contributions to smoking. Addiction (1997) 1.55
Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav (1992) 1.54
Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) (1997) 1.54
A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet (2003) 1.50
Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci (2003) 1.49
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol Learn Mem (2003) 1.49
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology (Berl) (2003) 1.49
Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci (2007) 1.48
Cigarette smoking among adults--United States, 1995. MMWR Morb Mortal Wkly Rep (1997) 1.46
Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus (2005) 1.44
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
Appetitive nature of drug cues confirmed with physiological measures in a model using pictures of smoking. Psychopharmacology (Berl) (2000) 1.44
Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci U S A (2001) 1.39
The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology (2002) 1.36
Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci (1997) 1.35
Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol (2008) 1.71
Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J Neurosci (2005) 1.68
Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J Neurosci (2007) 1.48
The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) (2005) 1.39
Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol Learn Mem (2007) 1.16
Nicotine enhances both foreground and background contextual fear conditioning. Neurosci Lett (2005) 1.13
beta2 subunit-containing nicotinic receptors mediate the enhancing effect of nicotine on trace cued fear conditioning in C57BL/6 mice. Psychopharmacology (Berl) (2006) 1.11
Nicotine enhances context learning but not context-shock associative learning. Behav Neurosci (2008) 1.09
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav Neurosci (2008) 1.07
Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Behav Genet (2011) 1.03
Neuronal nicotinic acetylcholine receptors: involvement in Alzheimer's disease and schizophrenia. Behav Cogn Neurosci Rev (2002) 1.02
Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiol Learn Mem (2012) 1.01
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav (2007) 0.99
Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment. Psychopharmacology (Berl) (2007) 0.99
Acute ethanol has biphasic effects on short- and long-term memory in both foreground and background contextual fear conditioning in C57BL/6 mice. Alcohol Clin Exp Res (2007) 0.98
The effects of acute, chronic, and withdrawal from chronic nicotine on novel and spatial object recognition in male C57BL/6J mice. Psychopharmacology (Berl) (2011) 0.97
Age-related impairment in the 250-millisecond delay eyeblink classical conditioning procedure in C57BL/6 mice. Learn Mem (2002) 0.97
Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. Eur Neuropsychopharmacol (2009) 0.96
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology (2007) 0.96
Gadd45b knockout mice exhibit selective deficits in hippocampus-dependent long-term memory. Learn Mem (2012) 0.96
Nicotine withdrawal disrupts new contextual learning. Pharmacol Biochem Behav (2008) 0.95
Associative learning, the hippocampus, and nicotine addiction. Curr Drug Abuse Rev (2008) 0.95
The hippocampus and cingulate cortex differentially mediate the effects of nicotine on learning versus on ethanol-induced learning deficits through different effects at nicotinic receptors. Neuropsychopharmacology (2009) 0.94
Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning. Hippocampus (2012) 0.93
Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotine. Behav Neurosci (2007) 0.93
Reversible inactivation of the entorhinal cortex disrupts the establishment and expression of latent inhibition of cued fear conditioning in C57BL/6 mice. Hippocampus (2007) 0.92
Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav Brain Res (2008) 0.92
Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology (2010) 0.92
Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus. Neuropharmacology (2010) 0.91
The interactive effects of nicotinic and muscarinic cholinergic receptor inhibition on fear conditioning in young and aged C57BL/6 mice. Pharmacol Biochem Behav (2004) 0.91
Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus. Psychopharmacology (Berl) (2012) 0.90
Effects of ethanol and caffeine on behavior in C57BL/6 mice in the plus-maze discriminative avoidance task. Behav Neurosci (2009) 0.88
Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors. J Neurosci (2013) 0.86
Rolipram attenuates MK-801-induced deficits in latent inhibition. Behav Neurosci (2005) 0.86
Effects of chronic low- and high-dose nicotine on cognitive flexibility in C57BL/6J mice. Behav Brain Res (2012) 0.86
The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. Behav Brain Res (2011) 0.85
Malleability in the development of spatial reorientation. Dev Psychobiol (2012) 0.85
Of mice (Mus musculus) and toddlers (Homo sapiens): evidence for species-general spatial reorientation. J Comp Psychol (2009) 0.85
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. Neuropsychopharmacology (2013) 0.84
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. Neurobiol Learn Mem (2008) 0.83
Interactive effects of ethanol and nicotine on learning, anxiety, and locomotion in C57BL/6 mice in the plus-maze discriminative avoidance task. Neuropharmacology (2009) 0.82
The enhancement of contextual fear conditioning by ABT-418. Behav Pharmacol (2010) 0.82
Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition. Psychopharmacology (Berl) (2014) 0.82
Learning and nicotine interact to increase CREB phosphorylation at the jnk1 promoter in the hippocampus. PLoS One (2012) 0.81
Latent inhibition of cued fear conditioning: an NMDA receptor-dependent process that can be established in the presence of anisomycin. Eur J Neurosci (2004) 0.80
Nicotine and ethanol enhancements of acoustic startle reflex are mediated in part by dopamine in C57BL/6J mice. Pharmacol Biochem Behav (2003) 0.80
Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning. Behav Brain Res (2013) 0.80
Comparison of the performance of DBA/2 and C57BL/6 mice in transitive inference and foreground and background contextual fear conditioning. Behav Neurosci (2012) 0.80
The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on performance of a cued appetitive response. Behav Neurosci (2013) 0.80
Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2014) 0.78
Signal transduction mechanisms within the entorhinal cortex that support latent inhibition of cued fear conditioning. Neurobiol Learn Mem (2007) 0.78
ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice. Behav Pharmacol (2015) 0.77
Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine Tob Res (2007) 0.76
Nicotine acts in the anterior cingulate, but not dorsal or ventral hippocampus, to reverse ethanol-induced learning impairments in the plus-maze discriminative avoidance task. Addict Biol (2011) 0.76
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies. J Clin Pharm Ther (2014) 0.76
Nicotinic receptors, memory, and hippocampus. Curr Top Behav Neurosci (2015) 0.76
Inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase disrupts latent inhibition of cued fear conditioning in C57BL/6 mice. Behav Neurosci (2004) 0.75